Becton, Dickinson and Company (BDX)
NYSE: BDX · Real-Time Price · USD
222.38
-0.02 (-0.01%)
Nov 21, 2024, 10:44 AM EST - Market open
BDX Revenue
Becton, Dickinson and Company had revenue of $5.44B in the quarter ending September 30, 2024, with 6.88% growth. This brings the company's revenue in the last twelve months to $19.83B, up 4.11% year-over-year. In the fiscal year ending September 30, 2023, Becton, Dickinson and Company had annual revenue of $19.37B with 2.66% growth.
Revenue (ttm)
$19.83B
Revenue Growth
+4.11%
P/S Ratio
3.25
Revenue / Employee
$271,616
Employees
73,000
Market Cap
64.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2023 | 19.37B | 502.00M | 2.66% |
| Sep 30, 2022 | 18.87B | -261.00M | -1.36% |
| Sep 30, 2021 | 19.13B | 3.06B | 19.02% |
| Sep 30, 2020 | 16.07B | -1.22B | -7.03% |
| Sep 30, 2019 | 17.29B | 1.31B | 8.18% |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
| Sep 30, 2015 | Pro | Pro | Pro |
| Sep 30, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CVS Health | 367.25B |
| McKesson | 330.19B |
| Cencora | 293.96B |
| GSK | 41.97B |
| Takeda Pharmaceutical | 31.73B |
| Haleon | 15.07B |
| Regeneron Pharmaceuticals | 13.85B |
| Alcon | 9.76B |
BDX News
- 21 hours ago - First of Its Kind HPV Self-Collection Study Launched to Improve Cervical Cancer Screening in Underserved Communities - PRNewsWire
- 1 day ago - BD to Present at the 7th Annual Evercore ISI HealthCONx Conference - PRNewsWire
- 8 days ago - Becton, Dickinson and Company Q4: Shifting To High-Growth Areas - Seeking Alpha
- 13 days ago - Becton, Dickinson and Company (BDX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Becton Dickinson beats quarterly estimates on strength in drug-delivery devices - Reuters
- 14 days ago - BD Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results - PRNewsWire
- 14 days ago - BD Board Increases Dividend for 53rd Consecutive Year - PRNewsWire
- 17 days ago - Becton, Dickinson And HP Among 13 Companies To Announce Annual Dividend Increases In First Half Of November - Seeking Alpha